Carrot Fertility  

Menlo Park,  CA 
United States
https://www.get-carrot.com

• Booth: 1836

Carrot Fertility is the leading global fertility care platform for women, who are often at the center of fertility care decisions and consequences. Plus, Carrot serves people of every age, race, income, sex, sexual orientation, gender, marital status, and geography. Trusted by hundreds of multinational employers, health plans, and health systems, Carrot's comprehensive clinical program delivers industry-leading cost savings for employers and award-winning experiences for millions of people worldwide. Whether there is a need for care through fertility preservation, male-factor infertility, pre-pregnancy, IVF, pregnancy and postpartum, adoption, gestational surrogacy, or menopause, Carrot supports members and their families through many of the most memorable and meaningful moments of their lives. Learn more at carrotfertility.com.

 Videos

 Press Releases

• Carrot Fertility Exceeds National Benchmarks for Fertility Success, Publishes New, Independently Validated Outcomes Study (Jun 22, 2023)

  18 Jan, 2023, 09:10 ET

  Carrot's study underscores its commitment to healthy outcomes through evidence-based care and confirms that Carrot has the highest single embryo transfer (SET) rate of any fertility benefits solution on the market with published outcomes

  MENLO PARK, Calif., Jan. 18, 2023 /PRNewswire/ -- Carrot Fertility, the leading global platform for fertility healthcare and family-forming benefits, announced today the publishing of the Carrot Study, demonstrating that Carrot exceeds national benchmarks for fertility success and has a single embryo transfer (SET) rate of 93%, the highest reported of any fertility benefits solution with published outcomes. The study concludes that Carrot's flexible plan design can meaningfully improve medical outcomes, including healthy pregnancies and successful future live births, without also contributing to the overuse of expensive and sometimes unnecessary interventions. 

  

  For this study, Carrot's Global Clinical Outcomes Division tracked the fertility outcomes of members enrolled in Carrot's benefits program and compared this data against national data from the Society for Assisted Reproductive Technology (SART). To evaluate the methodology that Carrot used to track and compare its key outcomes against national benchmarks, Carrot engaged Milliman, Inc., an independent global leader in actuarial services. The Milliman report can be viewed here. 

  "At Carrot, we've curated and manage the largest network of high-quality fertility clinics in the U.S. that provide the best possible care to our members," said Tammy Sun, Founder and CEO, Carrot Fertility. "The results of this study confirm that through our personalized, evidence-based care approach, we're delivering healthy outcomes and lowering costs for our customers by avoiding unnecessary medical interventions." 

  Carrot's fertility benefit solution combines active management of Carrot in-network providers and high-touch member support. To meet Carrot's eligibility criteria for network inclusion, Carrot providers must meet a set of distinct standards and hold certain credentials. 

  The three clinical outcomes reviewed in the Carrot Study include:

  • Single Embryo Transfer (SET) Rate
  • In Vitro Fertilization (IVF) Pregnancy Rate per Transfer
  • Pre-implantation Genetic Testing (PGT-A) Rate

  These measures are commonly used to assess the success of fertility treatments and the likelihood of a healthy singleton pregnancy and live birth. SET is the single most predictive indicator of a singleton IVF pregnancy and subsequent successful singleton live birth. It is an important clinical protocol used to avoid multiple-fetus pregnancies, which are associated with higher medical costs and poorer health outcomes for pregnant people and infants. Preterm birth, low birth weight, neurological impairment, and death are more common outcomes of multiple-fetus pregnancies compared to singleton pregnancies. Additionally, IVF pregnancy rates demonstrate the success rates of embryo transfers. PGT-A allows providers to assess the genetic status of an embryo prior to transfer and can improve IVF pregnancy rates, particularly in older populations. However, in other populations, PGT-A has been shown not to impact IVF pregnancy rates and can instead pose a risk to the tested embryos. Utilization of PGT-A among Carrot members is aligned with the patient demographics where PGT-A is recommended. Carrot's data shows that its program can improve IVF pregnancy rates without requiring PGT-A as an additional expense in all cases. 

  "For years, Carrot's personalized care navigation has met members where they are and optimized for healthy outcomes and cost-effectiveness," said Dr. Asima Ahmad, Co-founder and Chief Medical Officer, Carrot Fertility. "This study further validates our team's work to provide education around medically-appropriate care based on the latest clinical guidelines. We're proud to offer a benefit that makes a meaningful impact on our members' lives." 

  Carrot's flexible program enables access to personalized, evidence-based care based on member needs, rather than prescribing a predefined course of treatments in a one-size-fits-all approach. Members receive medical care within Carrot's vetted provider network and seek additional guidance and around-the-clock support through Carrot's team of care navigators and fertility experts. Carrot's coverage is comprehensive, age inclusive, and provides benefits across a wide variety of member journeys, including fertility, pregnancy, adoption, gestational surrogacy services, menopause, low testosterone, and more.

  As the leader in global fertility healthcare, Carrot is the trusted benefits solution for more than 800 companies, including Box, Ferring, Peloton, Reed Smith, and Snap, Inc. To learn more about the Carrot Study and how Carrot works with employers and health plans, please visit www.carrotfertility.com. 

  About Carrot Fertility

  Carrot is the leading global platform for fertility healthcare and family-forming benefits. Trusted by hundreds of the world's best multinational employers, health plans, and health systems, Carrot's comprehensive clinical program delivers industry-leading cost savings for employers and exceptional experiences for millions of employees. Its award-winning product serves all populations – inclusive of age, sex, sexual orientation, gender identity, race, marital status, and geography. Whether there is a need for care through fertility preservation, male-factor infertility, pre-pregnancy, IVF, pregnancy and postpartum, adoption, gestational surrogacy, or menopause, Carrot supports members and their families through many of the most memorable and meaningful moments of their lives. 

  Carrot has received national and international recognition for its pioneering work, including Best Diversity, Equity, & Inclusion Product from the Anthem Awards, Fast Company's Most Innovative Companies, CNBC's 100 Barrier Breaking Startups, and more. Carrot is regularly featured in media reporting on issues related to the future of work, women in leadership, healthcare innovation, and diversity, equity, and inclusion, such as The Economist, Bloomberg, Elle Magazine (Japanese edition), The Wall Street Journal, ABC, CNBC, National Public Radio, Harvard Business Review, and more. 

  Carrot is fully distributed, with teams in more than 40 states across the United States and dozens of countries around the world. It has received numerous workplace awards, including Fortune's Best Workplaces in Healthcare, Great Places to Work certified, and certified Age-Friendly Employer. Learn more at carrotfertility.com. 

• First-of-its-kind "Global Fertility at Work" Report from Carrot Fertility Reveals Financial Burden and Workplace Stigma are the Biggest Roadblocks to Accessing Fertility and Family-Forming Care (Jun 22, 2023)

  NEWS PROVIDED BY

  Carrot Fertility 

  18 Apr, 2023, 09:00 ET

  Survey results reveal a universal need for better fertility support at work, with only 32% of professionals seeking to grow their families able to afford fertility treatment, and 42% saying that a new job offer with no fertility benefits would be a "deal breaker"

  MENLO PARK, Calif., April 18, 2023 /PRNewswire/ -- Employees around the globe actively seeking to grow their families face significant challenges and are eager for more support from employers, according to a new Global Fertility at Work report from Carrot Fertility. As the leading global fertility care platform for women+, the company surveyed 5,000 people across Canada, India, Mexico, UK, and the U.S. to understand how people around the world feel about fertility topics at work, assess programs currently in place, and learn how they can be better supported at work in their fertility and family-forming journeys. This report is being released ahead of National Infertility Awareness Week, which is recognized during the week of April 23rd in the U.S. and Canada.

  Financial and workplaces challenges are the biggest barriers to family-forming
  Despite universal societal pressure (91%) to build a family, with the most common from a parent asking for grandchildren (49%), the survey reveals that the two biggest roadblocks to starting a family are financial challenges (63%), followed closely by workplace challenges (55%), including considerations such as career growth.

  For employees looking to start or grow their families, just 32% say they can afford fertility treatments if needed. For those lacking financial resources, 29% reported they may incur debt, and 39% would tap savings. Further, to cover these debts, bank loans are the top financing option (47%) globally, though Americans and Canadians would be more likely to take on a second job. Additionally, 41% of Americans would sell possessions – the highest such global stat.

  The new report also underscores the negative impact of fertility healthcare stress on productivity at work. Among respondents, 65% have spent time at work researching fertility treatments, benefits, and family-forming. Meanwhile, 55% report that fertility challenges have detrimentally impacted their work performance.

  Workplace fertility benefits are critical to recruitment, retention, and inclusivity
  The report spotlights the role employers can play to not only ease many of the pain points employees feel from the workplace environment, but also position companies to succeed. Across the globe, there is overwhelming employee support for employer-provided fertility benefits, which are deemed critical to recruitment, retention, and inclusivity.

  Among respondents, 65% would change jobs to work for a company that offers fertility benefits, 65% would ask about fertility benefits before accepting a new job offer, and 62% would even consider taking a second, part-time job with fertility benefits. For 42%, if fertility benefits aren't offered for a new job, it's a "deal breaker." Retention is also a significant draw, with 72% committing to stay at a company longer if they had access to fertility benefits. Moreover, 75% consider fertility benefits at work to be an important part of an inclusive company culture.

  Significant demand for fertility benefits presents opportunities for employers
  There is substantial employee demand for fertility benefits in the workplace, presenting an opportunity for employers to enhance their benefits offerings to attract and retain talent. More than 60% believe that employees in their country should have better access to fertility benefits in the workplace.

  The survey also reveals additional opportunities for employers to support their workforces, specifically through both an improved culture and better benefits. Nearly all respondents (97%) expressed a desire for better workplace culture for those trying to build a family or experiencing fertility challenges, with "better emotional or mental health resources" (63%) being the most popular solution. When employers do offer fertility benefits, specialized emotional and mental health tailored for fertility care experiences support are the most common such benefits and considered most valuable (53%).

  Similarly, 97% expressed a desire for more employer-led support in addressing fertility care needs in the workplace, with fertility benefits being the top global solution (59%).

  "This new global report validates an important reality we have known for years: fertility is not only a healthcare issue, but also a global workplace concern," said Tammy Sun, Founder and CEO, Carrot Fertility. "These results demonstrate just how essential comprehensive fertility healthcare and family-forming support is for employees worldwide and showcase the opportunity employers have to make impactful investments in this critical part of healthcare."

  Discussion of fertility at work is more taboo than politics or religion
  Exacerbating the challenges many employees on their family-forming journeys encounter in the workplace, attempts to talk about fertility with colleagues and managers is very much taboo. The vast majority of employees (79%) feel uncomfortable discussing it openly at work, primarily because it could be perceived as unprofessional. In fact, according to respondents, even topics like politics and religion are more acceptable workplace conversations than subjects like pregnancy challenges, pregnancy loss, or menopause.

  Moreover, 33% are uncomfortable having these discussions in private with a supervisor or manager and 28% are uncomfortable discussing directly with colleagues.

  Methodology
  Carrot commissioned this scientific random sample of 5,000 respondents equally representing five countries (Canada, Mexico, India, UK, U.S.) between the ages of 25 and 40, currently employed for wages, and are either in the planning stages or actively building a family. The survey was fielded between March 9 and March 13, 2023, and has a margin of error of 1.4% with 95% confidence.

  About Carrot Fertility 
  Carrot Fertility is the leading global fertility care platform for women, who are often at the center of fertility care decisions and consequences. Plus, Carrot serves people of every age, race, income, sex, sexual orientation, gender, marital status, and geography. Trusted by hundreds of multinational employers, health plans, and health systems, Carrot's comprehensive clinical program delivers industry-leading cost savings for employers and award-winning experiences for millions of people worldwide. Whether there is a need for care through fertility preservation, male-factor infertility, pre-pregnancy, IVF, pregnancy and postpartum, adoption, gestational surrogacy, or menopause, Carrot supports members and their families through many of the most memorable and meaningful moments of their lives.

  Carrot has received national and international recognition for its pioneering work, including Best Diversity, Equity, & Inclusion Product from the Anthem Awards, Fast Company's Most Innovative Companies, CNBC's 100 Barrier Breaking Startups, and more. Carrot is regularly featured in media reporting on issues related to the future of work, women in leadership, healthcare innovation and diversity, equity, and inclusion, including MSNBC, The Economist, Bloomberg, The Wall Street Journal, CNBC, National Public Radio, Harvard Business Review, and more.

  Carrot is fully distributed, with teams in more than 40 states across the United States and dozens of countries around the world. It has received numerous workplace awards, including Fortune's Best Workplaces in Healthcare, Quartz's Best Companies for Remote Workers, and Great Place to Work and Age-Friendly Employer certifications. Learn more at carrotfertility.com.

• Carrot expands award-winning menopause and low T product with global support for hormone replacement therapy (Jun 22, 2023)

  March 28, 2023 | Carrot Fertility

  Carrot announced today the expansion of its clinically-validated menopause and low testosterone (low T) product with the addition of hormone replacement therapy (HRT) coverage. Carrot members will have access to HRT medication coverage to effectively manage menopause and low T symptoms, including the ability to order through Carrot Rx. Additionally, members will have access to virtual and in-person clinic visits with doctors, nurses, and other experts who specialize in menopause and low T care. This first-of-its-kind offering expands access to HRT for people experiencing menopause and low T in every major region worldwide, including North America, Europe, Asia, and Australia.

  Major gaps in care for perimenopause, menopause, and low testosterone (low T) exist in nearly every healthcare system around the world. In the United States, for example, fewer than 20% of all OB/GYNs are trained in menopause care. Unfortunately, finding a provider is only the first challenge. From there, it is often difficult for patients to then access the right personalized hormonal prescription medication that is most effective for each individual. While public and private healthcare systems provide some coverage for hormone replacement therapy, significant gaps exist. Conflicting guidance around HRT has led health insurance plans to offer only limited coverage, with many medications not fully covered and newer, innovative treatments often not covered at all. Men experiencing low T often struggle with existing solutions that may not meet national control guidelines and provide the necessary medical education. 

  As a result, millions of people – especially women – are unable to access care that can dramatically improve their fertility health and quality of life, including increased productivity at work. In a recent report published by Carrot, women ranked their 50s as the most challenging decade for being in the workforce, nearly half have considered changing jobs to find remote work so they can better manage symptoms, and about 1 in 4 considered retiring early due to menopause. 

  “The dramatic hormonal changes seen during menopause and age-related low T can negatively impact people physically, mentally, and emotionally and, unfortunately, many treatment options are not covered by health insurance,” said Dr. Asima Ahmad, Co-founder and Chief Medical Officer, Carrot Fertility. “With both provider matching through Carrot's menopause and low T network and coverage for HRT, members can now get the comprehensive care they need, when they need it.”

  With Carrot, members will now be able to access personalized hormonal care with the most comprehensive formulary currently available to support this area of fertility healthcare. For U.S. members, this includes the ability to easily order HRT medications through Carrot Rx, the company’s virtual pharmacy, available in all 50 states. Carrot Rx provides 24/7 clinician support for understanding these complex medications as well as ensuring testosterone is safely and legally distributed. Additionally, members will have access to virtual and in-person clinic visits with doctors that specialize in menopause and low T care. Carrot’s award-winning menopause and low T support has been recognized by Fast Company and the Anthem Awards for destigmatizing these topics in the workplace and being the first fertility benefits platform to offer clinically-validated, age-inclusive fertility benefits. 

  Since first introducing menopause and low T support last year, more than half of Carrot’s customers have added comprehensive support for menopause and low T as part of their fertility benefits package. For Carrot members, that means they have improved access to providers through a specialized network, clinically backed education, intimate group support in our virtual community, and, moving forward, HRT coverage. Members can opt into a personalized Carrot Plan, receive telehealth access to specialized experts, participate in expert-led group sessions, access Carrot-vetted providers that support menopause and low T, and access additional resources, including registered dieticians and psychologists.